Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on May 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 48,800 ...

Guggenheim analyst Vamil Divan reiterated a Buy rating on Savara yesterday and set a price target of $11.00. The company’s shares closed yesterday at $5.08. Claim 55% Off TipRan ...

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 ...

New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have ...

In the last week, the market has stayed flat, yet it is up 24% over the past year with earnings forecasted to grow by 17% annually. In such a vibrant market environment, identifying undervalued stocks ...

The United States market has remained flat over the last week, yet it has experienced a 24% rise over the past 12 months with earnings forecast to grow by 17% annually. In such an environment, ...

The Lutzie 43 Foundation selected 20 college and high school students as recipients of the 2026 $4,300 Prepared for Life (PFL ...

Last Chance for Animals (LCA), alongside the Anti-Vivisection Alliance, Direct Action Everywhere Toronto, Animal Rights Toronto, and advocates Vikki Lenola and Jenny McQueen, will host a peaceful ...

Insight Molecular Diagnostics Inc., formerly Oncocyte Corporation, is a molecular diagnostics technology company. The Company's technology quantifies a molecular biomarker known as donor-derived ...